Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Update

31 May 2012 07:00

RNS Number : 4649E
Biome Technologies PLC
31 May 2012
 



Biome Technologies plc ("Biome", "the Company" or "the Group")

Trading Update

 

In the trading statement released by Biome on 25 April, it was stated that revenues were slower to achieve than expected in the first quarter, particularly in the Bioplastics Division. Unfortunately, sales within this division have been markedly below our expectation during April and May. The Board now believes that this will have a significant adverse impact on the Group results for the full year; this will be particularly felt in the first half. The RF Division is trading in line with the Board's expectations and its order pipeline remains strong.

 

Customers of the Group's Bioplastics Division are reporting subdued demand for their own bioplastic end products, particularly in the markets of southern Europe. During 2011, the Italian market for bioplastics became one of the largest in Europe following the implementation of regulations (first introduced in early 2011 and reaffirmed in early 2012) mandating the use of biodegradable products for shopping bags. However, in the early part of May this year Biome became aware that the financial penalty for non-compliance with these regulations would now be deferred until the end of 2013. This has resulted in the recent and significant change in the adoption rate in the Italian market and a broader disruption to the supply and demand balance of bioplastics in Europe. In the current, year the Board expects its joint venture company, Biotec, to be the most adversely affected part of the Group.

 

The impact of these changes to the dynamics of the bioplastics' market will result in it taking longer than previously anticipated for the Group to reach profitability. The Group's cash balance as at the end of April was £1.4m. However, this would have reduced significantly as the year progressed unless action is taken to reduce costs. As a result, the Board is taking steps to reduce cash costs by approximately £600k per year. This will better preserve Biome's ability to reach profitability and protect its business model.

 

Whilst the above developments, which affect the fast development of Biome's bio-plastics market, are disappointing, the Board believes firmly that they constitute a pause in a fast-developing market rather than an indication of anything more fundamental.

 

Biome continues to progress successfully with new products and technologies to improve its future prospects and develop new markets. The RF Division is performing well and remains a cash generator for the group as a whole. The Durapipe project remains on track and is successfully passing agreed milestones with our partner. The new technology for heat and cold resistant bio-plastic materials continues to gain positive reaction from product tests with prospective customers. The Board expects these new developments to make contributions to turnover in 2013.

 

-Ends-

 

 

For further information please contact:

 

Biome Technologies plc

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com Tel: +44 (0) 2380 867 100

 

Daniel Stewart & Company plc

David Hart

www.danielstewart.co.uk Tel: +44 (0) 20 7776 6550

 

First Columbus

Chris Crawford/Kelly Gardiner

www.first-columbus.com Tel: +44 (0) 20 3002 2070

 

FTI Consulting

Oliver Winters/Latika Shah Tel: +44 (0) 20 7831 3113

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBKKDPABKDBPN
Date   Source Headline
23rd Mar 20219:05 amRNSSecond Price Monitoring Extn
23rd Mar 20219:00 amRNSPrice Monitoring Extension
23rd Mar 20217:00 amRNSContract
17th Mar 20217:00 amRNSUpdate on biodegradable tree shelter project
16th Mar 20217:00 amRNSBiome commits to UN Race to Zero climate campaign
28th Jan 20217:00 amRNSTrading Update
13th Jan 20217:00 amRNSUpdate on biodegradable tree shelter project
31st Dec 20201:30 pmRNSTotal Voting Rights
15th Dec 20207:00 amRNSBiome's RF division gains traction
11th Dec 20208:05 amRNSAdmission of Subscription Shares
6th Nov 20204:41 pmRNSSecond Price Monitoring Extn
6th Nov 20204:35 pmRNSPrice Monitoring Extension
4th Nov 20207:00 amRNSBiome starts biodegradable tree shelter project
30th Oct 20205:00 pmRNSTotal Voting Rights
30th Oct 20207:00 amRNSDirector/PDMR Shareholding
29th Oct 20207:01 amRNSAppointment of Group Chief Financial Officer
29th Oct 20207:00 amRNSTrading Update
22nd Oct 202012:28 pmRNSHolding(s) in Company
19th Oct 20202:17 pmRNSHolding(s) in Company
12th Oct 20204:07 pmRNSResult of General Meeting
1st Oct 202010:55 amRNSHolding(s) in Company
24th Sep 20207:05 amRNSProposed Fundraise of £1.1 million & Notice of GM
24th Sep 20207:00 amRNSInterim Results
26th Aug 20207:00 amRNSGrant funding from Innovate UK
19th Aug 20207:00 amRNSOrder for compostable bioplastic for coffee pods
30th Jul 20207:00 amRNSTrading Update
25th Jun 20203:46 pmRNSResult of Annual General Meeting
2nd Jun 202010:35 amRNSNotice of Annual General Meeting 2020
22nd Apr 20207:00 amRNSTrading Update
20th Apr 20202:16 pmRNSAnnual Report and Accounts
16th Apr 20207:00 amRNSFinal Results 2019
25th Mar 20207:00 amRNSUpdate re Final Results, 2019 Annual Report & AGM
13th Feb 20204:01 pmRNSNotification of awards under the 2017 LTIP
30th Jan 20204:10 pmRNSShare option awards in lieu of historic bonuses
30th Jan 20207:00 amRNSTrading statement and Board change
4th Nov 20197:00 amRNSBiome to present at Mello London 2019
31st Oct 20195:30 pmRNSTotal Voting Rights
31st Oct 20197:00 amRNSTrading update
30th Sep 20193:04 pmRNSResult of General Meeting
12th Sep 20197:05 amRNSProposed Placing to raise £1.3 million
12th Sep 20197:00 amRNSInterim Results
22nd Jul 20197:00 amRNSTrading Update
25th Jun 20199:17 amRNSLong Term Incentive Plan Second Vesting
17th Jun 20194:12 pmRNSDirector/PDMR/PCA Shareholding
14th Jun 20197:00 amRNSBioplastics Product Update
24th Apr 20191:59 pmRNSResult of Annual General Meeting
24th Apr 20197:00 amRNSTrading Update
4th Apr 201912:20 pmRNSDirector/PDMR/PCA Shareholding
29th Mar 20199:22 amRNSNotice of AGM and Annual Report
28th Mar 20197:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.